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The role of butyrylcholmesterase (BuChE) and acetylcholmesterase (AChE) in regulating acetylcholine (ACh) lifetime was investigated by use of 
selective cholinesterase (ChE) inhibitors. Addition of 1 PM tetraisopropylpyrophosphoramlde (ISO-OMPA) led to a 98% inlubltion of BuChE activi- 
ty with httle or no effect on AChE activity This inhIbItion wa accompamed by a 26% increase m the amplitude and a 43% prolongation in the 
half-relawatlon time of contractions ehclted by electnc field stimulation (EFS) Coapplicatlon of BW 284C51 (a selective AChE inhibltor) and 1 
PM ISO-OMPA resulted m increases of 2-fold in the amplitude and lo-fold m the half-relaxation time of EFS-Induced contractions. These aIteratIons 
were accompamed by small but sustained baseline contractures that were antagonized completely by incubation with exogenous BuChE (2.5 U/ml). 
The results suggest that BuChE serves to coregulate the hfetime of ACh m camne tracheal smooth muscle. 
Pseudocholmesterase; Acetylcholinesterase. Tetralsopropylpyrophosphoramlde. BW 284C51 
1. INTRODUCTION 
At all cholinergic synapses thus far investigated, 
acetylcholine (ACh) action is terminated by rapid 
hydrolysis of excess transmitter. This hydrolysis is nor- 
mally mediated by the enzyme acetylcholinesterase 
(AChE; EC 3.1.1.7; acetylcholine hydrolase), which 
rapidly degrades ACh into choline and acetate [l]. 
Another ACh hydrolyzing enzyme, butyrylcholine- 
sterase (BuChE; EC 3.1.1.8; acylcholine acylhydrolase; 
pseudocholinesterase) is found primarily in plasma but 
is also present in appreciable quantities in cardiac and 
smooth muscle fibers and autonomic ganglia [2-51. 
Unlike AChE, BuChE has generally been considered to 
have no defined physiological function [5,6]. This 
stems, in part, from the low activity of BuChE in most 
cholinergic synapses such as those in skeletal muscle 
and the CNS [7]. 
tion by AChE is likely, based on its well known role in 
hydrolyzing ACh at neuromuscular and ganglionic 
synapses [lO,ll]. A contribution by BuChE is also 
possible, since in canine TSM, this enzyme comprises 
the majority of ChE active sites [8]. However, to be 
functional, BuChE must have a sufficiently high 
substrate affinity and catalytic activity to eliminate ex- 
cess ACh and prevent transmitter accumulation. 
In canine tracheal smooth muscle (TSM), 
cholinesterase (ChE) inhibitors produce an increased 
sensitivity to exogenous ACh, an enhanced contraction 
in response to electric field stimulation (EFS) and a sus- 
tained increase in baseline tension [8,9]. It is not clear 
whether these alterations result from inhibition of 
AChE, BuChE or both since most ChE inhibitors show 
little selectivity between the two enzymes. A contribu- 
To test the possibility that BuChE has a functional 
role in canine TSM, we examined the actions of the 
selective inhibitor of BuChE (tetraisopropylpyrophos- 
phoramide, iso-OMPA) and of AChE (1,5-(bis(N-allyl- 
h!N-dimethyl-4-ammoniumphenyl)-pentane-3-one di- 
bromide, BW 284C51), respectively, on spontaneous 
and EFS-elicited muscle tensions. Inhibition of either 
BuChE or AChE resulted in slight to moderate in- 
creases in EFS-induced contractions whereas combined 
inhibition of both enzymes led to a marked potentia- 
tion of such contractions as well as the production of 
sustained baseline tension. The results indicate that 
BuChE contributes to ACh hydrolysis in canine TSM; 
this effect is most pronounced when AChE is also in- 
hibited. 
2. MATERIALS AND METHODS 
2.1. Muscle tension 
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Tracheae were removed from mongrel dogs under pentobarbital 
anesthesia (30 mg/kg, i.v.), freed of loose connective tissue and 
mucosa and sectioned into 2 x 10 mm rectangular strips. Isometric 
tensions were recorded at 37°C in 10 ml chambers containing OX- 
ygenated (95% 02, 5% COz) Tyrode’s solution of the following com- 
posltion (mM): NaCI, 137; KCl, 2.7; NaHCO3, 11.9; NaHzPO+ 0.3; 
MgClz, 0.5; CaC12, 1.8; glucose, 5.6; pH 7.4. Tensions were recorded 
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with Grass FT 0.03 force displacement transducers and displayed on 
a Gould chart recorder and Honeywell FM tape recorder. TSM strtps 
were equilibrated for 1 h prtor to recordmg at a resting tension of 4 g. 
Contractions were elicited by electrtcal pulses applied between pans 
of platinum electrodes vta Grass S-88 stimulators. The pulses were 
50 V and 1 m\ delivered rn trains of 10 Hz for 20 s. 
2 2. ChE acrlvrtv 
Unless stated otherwise, a radiometrtc assay was used to measure 
ChE activity [12]. The experiments were performed on strips to hmit 
the responses to surface enzymes [13]. Total activtty was determmed 
by use of [‘JC]ACh, whereas BuChE and AChE acttvtttes were 
evaluated by use of [r”C]butyrylcholine (BuCh) and [“Clacetyl-$- 
methylcholine (MeCh), respectively. Selecme inhibition of AChE 
and BuChE was achieved by addition of BW 284CSl and rso-OMPA, 
as appropriate The reactton was termtnated by addttion of Amberhte 
CG-120 suspended in 1,4-dtoaane to remove unhydrolyzed substrate. 
The samples were centrtfuged briefly to sediment the Amberhte. The 
radioactivity m the supernatant was counted m a Beckman acmttlla- 
tion spectrometer. 
2.3. Kinetrc conslants 
To obtain kmetic data, ChE activtty was measured by the pro- 
cedure of Ellman et al. [14] Total activity was assessed by mcubatrng 
muscle homogenates at 37°C and pH 8.0 wtth acetylthtocholine at 
concentrations ranging from 10 pM to 30 mM m a Tttertek Multiscan 
Model hlCC plate reader (Flow Labs, Mclean, VA). The contrtbu- 
ttons of AChE and BuChE were evaluated by preincubatmg the 
homogenates for 30 mm with 1 pM iso-OXIPA or 1 FM BW’ 284C5 I, 
a5 appropriate. The parameters K,,, and t,‘,,,,, were estimated from 
double-rectprocal plots of substrate-celoctty data m the low ,ub,trate 
concentration range (IO/CM to 1 mM). 
2.4. Materrals 
BW 284C5 1, iso-OMPA, acetylthtochohne chlorrde and 
butyrylthiocholine chloride and BuChE type VII were obtained from 
the Sigma Chemical Co., St. Louis, MO. Radiolabeled substrates 
were purchased from New England Nuclear Research Products (Du- 
Pont), Boston, MA. Soman was synthestred by the Chemical 
Research, Development and Engmeertng Center, Aberdeen Proving 
Ground, MD. 
3. RESULTS 
3. I. Differential and combined inhibition of ChE 
The effects of BW 284C51 and iso-OMPA on EFS- 
induced contractions are shown in Fig. 1, and the cor- 
CONTROL BW264C51 
iso-OMPA WASH. 60 mln 
responding alterations in ChE activities are displayed in 
Fig. 2. In the presence of 1 ,xM BW 284C51, the EFS- 
evoked contractions increased by 76 + 6.3% in 
amplitude and by 129 + 8.1% in duration (Fig. 1). 
Under these conditions, AChE activity was reduced to 
22% of control, as indicated by the impaired hydrolysis 
of MeCh, while BuChE activity was not significantly 
altered (Fig. 2). 
Addition of 1 AM iso-OMPA led to increases of 26 ? 
2.3% and 43 ~fr 5.9%, respectively, in the amplitude 
and half-relaxation time (HRT) of the EFS-induced 
contractions (Fig. 1). At 1 ,uM, iso-OMPA produced a 
selective and nearly total abolition of BuChE activity 
(Fig. 2). The alterations induced by iso-OMPA were ir- 
reversible. as indicated by the absence of recovery even 
after a 1 h wash in control Tyrode’s solution (Fig. 1). 
Reapplication of BW 284C51 to preparations 
pretreated with iso-OMPA or coapplication of BW 
284C51 with iso-OMPA caused a further increase in the 
contraction amplitude and a striking prolongation in its 
decay (Fig. 1). The effect of the combined ChE in- 
hibitors on the HRT was considerably greater than that 
observed with either inhibitor alone or than that ex- 
pected from their linear addition. Since, at the concen- 
trations used, there is little overlap in the specificities of 
BW 284C51 and iso-OMPA on enzyme activity 
(Fig. 2), the potentiation must result from the 
simultaneous inhibition of both enzymes. 
3.2. Antagonism by exogenous BuChE 
To substantiate the role of BuChE in coregulating 
ACh lifetimes in canine TSM, we examined the effects 
of exogenous BuChE on EFS-induced tensions and sus- 
tained muscle contractures. The results of a represen- 
tative experiment are shown in Fig. 3. A marked 
potentiation was observed in the EFS-induced contrac- 
tion by co-applying 1 ,YM BW 284C51 with 1 PM iso- 
OMPA for 30 min (Fig. 3A). These alterations were ac- 
companied by a 4.2 g increase in the baseline tension 
WASH, 10 mm WASH, 60 mln 
BW264C51 
m 2og., 
Frg. 1. Traces tllustratmg the differential and combmed mhtbitton of AChE and BuChE on EFS-induced contractions from canme TSM. The 
data were obtained from one muscle strip exposed to the inhibitors BW 284C51 (1 pM) and iso-OMPA (1 yM) in the sequence shown. An 
equilibration period of 230 min preceded the recordings. The initial 10 min of BW 284C51 washout was accompamed by an Increase in the 
amplitude and HRT of the EFS-Induced contractton followed by a return to the control configuration with contmued wash. The transient 
potenttation results from a rapidly reverstble anttmuscarinic actton of BW 284C51. The last trace was obtamed followmg reapphcation of BW 
284C51 after irreversible inhrbttion of BuChE by iso-OMPA. Thts response ts superimposed on a 3.3 g contracture (not shown). 
108 
Volume 267, number 1 FEBS LETTERS July 1990 
lpa ma-OMPA 
Fig. 2. Histograms showing the effects of BW 284C51 and iso- 
OMPA on surface ChE activity m canme TSM. The data were 
obtained by incubating 9-12 muscle strips in BW 284C51, iso-OMPA 
or both for 30 min and assaying for BuChE, AChE and total ChE 
activities using the substrates BuCh, MeCh and ACh, respectively. 
Bars denote the SE. 
(Fig. 3B). Excess iso-OMPA was removed by washout 
with a solution containing only the reversible BW 
284C51, and a commercial preparation of BuChE 
(Sigma type VII) was then added to the bathing 
medium. As is clear, the duration of the EFS-induced 
contraction was markedly reduced following a 40 min 
incubation with BuChE (2.5 U/ml). Exogenous BuChE 
also caused complete relaxation of the contracture. 
Both effects persisted for up to 3 h but could be revers- 
ed by washout with enzyme-free solution or re- 
admission of iso-OMPA (unpublished observations). 
These results are of interest, since they reveal the ability 
of diffusely applied BuChE to hydrolyze ACh released 
both under resting conditions as well as during stimula- 
tion. The former is considered to represent nonquantal 
release [15]. 
3.3. ~et~rrn~~ati~~ of kinetic constants 
Since BuChE apparently contributes to transmitter 
hydrolysis in canine TSM but has not been reported to 
have this action in most preparations [7], it was of in- 
terest to determine whether BuChE from canine TSM 
possesses unique catalytic properties, i.e. to test 
whether its activity in airway smooth muscle is unusual- 
ly high. 
Fig. 4 shows the relationship between substrate con- 
centration and hydrolytic activity for AChE and 
BuChE as determined by the calorimetric method of 
Ellman et al. [14]. AChE activity increased initially 
with increases in acetylthiocholine concentration, 
became maximal at approximately 1 mM and decreased 
thereafter (Fig. 4A). The decrease in activity is due to 
substrate inhibition, a characteristic property of AChE 
[ 161. From double reciprocal plots in the low substrate 
concentration range (10 pM to 1 mM), values for V,,, 
and Km were estimated to be 2.8 t- 0.23 pmol/min/g 
CONTROL EW 284C51 BuChE 
BuChE 60 set 
I - 
Fig. 3. Effect of exogenous BuChE on EFS-induced contractions and 
basal tone. (A) A 30 min exposure to 1 PM ISO-OMPA and I ,ILM BW 
284C51 caused a marked potentiation in the amplitude and HRT of 
EFS-induced contractions. The effect on HRT was partially 
antagonized followmg a 40 min incubation with BuChE (Sigma type 
VII, 2.5 U/ml). Train durations were for 20 s as indicated by the 
horizontal bars. (B) BuChE (2.5 U/ml) produced complete relaxation 
of the 4.2 g contractton resulting from combined addition of BW 
284C51 and iso-OMPA. Baseline is indicated by the interrupted hne. 
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Fig. 4. (A) Substrate-velocity plots for hydrolysis of 
acetylthiocholine in canine TSM homogenates. AChE (circles) and 
BuChE (squares) activities were obtained by use of iso-OMPA and 
BW 284C51, respectively. The points represent the mean f SE (n = 
6) of mittat velocities determined by the calorimetric method of 
Ellman et al. 1141. (B) Double reciprocal plots of the means of the 
data in (A) over the substrate concentration range 1OpM to 1 mM. 
The units for the ordinate and abscissa are bmol/min/g)-’ and 
(mM-‘), respectively. 
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tissue and 87 i- 11 PM, respectively (n = 6) (Fig. 4B). 
The latter is in accord with values for AChE obtained 
from brain, skeletal muscle and erythrocytes [7]. 
BuChE was less active than AChE at 
acetylthiocholine concentrations 5 100 FM but showed 
greater activity at higher substrate concentrations. This 
enzyme also deviated from simple Michaelis-Menten 
kinetics. However, it was activated rather than in- 
hibited by high substrate concentrations [17]. From 
double-reciprocal plots, k’, for BuChE was calculated 
to be 634 +- 81 PM (n = 6). This value is similar to those 
reported for BuChE from plasma [5], autonomic 
ganglia [3] and intestinal smooth muscle [13]. V,,, for 
BuChE could not be determined accurately, since the 
substrate-velocity relationship did not saturate even 
with 30 mM acetylthiocholine (Fig. 4A). 
4. DISCUSSION 
The role of AChE in regulating cholinergic synapses 
is well established, but there is no general agreement 
regarding the role of BuChE. An impression that 
BuChE is not involved in cholinergic transmission 
originated from findings that inhibition of this enzyme 
in vivo produces no obvious toxicity [ 181. This impres- 
sion has been reinforced by findings that humans with 
relatively inactive genetic variants of BuChE do not ex- 
hibit signs of impaired cholinergic function [ 191. 
However, as early as 1950, Koelle et al. [2] 
demonstrated that selective inhibition of BuChE leads 
to enhanced contractility in isolated ileal strips. The ap- 
parent discrepancy between this and the above results 
can be reconciled by noting that in vertebrates there is 
little BuChE activity in critical tissues such as brain and 
skeletal muscle; even where BuChE is substantial, it is 
always accompanied by AChE [ 191. 
The results of the present investigation provide 
evidence for a functional role of BuChE in canine 
TSM. This conclusion is based on findings that selec- 
tive inhibition of BuChE leads to significant increases 
in the amplitude and HRT of EFS-evoked contractions. 
Although functional, the efficacy of BuChE was con- 
siderably lower than that of AChE. This was indicated 
by findings that 1 PM BW 284C51, which inhibited 
78% of AChE, produced more pronounced alterations 
of EFS-induced contractions than did 1 FM iso- 
OMPA, which inhibited 98% of BuChE (Figs 1 and 2). 
The relatively greater effect of AChE blockade may be 
explained by its higher rate of ACh hydrolysis at con- 
centrations below 1 mM (Fig. 4). The differences in the 
catalytic properties of the two enzymes are reflected in 
the 7.3-fold lower K, (higher affinity) for AChE 
relative to BuChE when acetylthiocholine was used as 
substrate. 
It is appropriate at this time to ask what role BuChE 
plays in the normal physiology of canine TSM. 
Although shown to coregulate ACh lifetime in the pre- 
110 
sent study, the use of BuChE for this purpose may ap- 
pear to be inefficient since a much larger number of 
BuChE than AChE molecules are required to produce 
equivalent catalysis. However, since BuChE is ac- 
tivated and AChE is inhibited with high substrate con- 
centrations (Fig. 4A), BuChE becomes the dominant 
enzyme when substrate concentrations exceed 1 mM. 
Thus, the primary role of BuChE may be to hydrolyze 
transmitter under conditions of high release and 
therefore to protect the TSM from excess ACh levels. 
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